HBS Sweden (investor - Corporate Investor)
See something wrong or missing? Let us know
Offices:Malmö
HBS-Sweden AB was founded in 2008. The Company's line of business includes the wholesale distribution of prescription drugs, proprietary drugs, and toiletries.
Average round investment:2.26M USD
Average number per year:1.0
Distribution:
2017 (1)
Portfolio companies:
Ngager

Mostly invests in:
Sweden (1)
Industry agnostic (1)

1 tracked investments in:
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Investors with similar profile to HBS Sweden
Name | Criteria | |
---|---|---|
![]() |
Bling Capital
62%
|
|
![]() |
Christer Olsson
62%
|
|
Daniel Curran
62%
|
|
|
![]() |
Formica Capital
62%
|
|
![]() |
Mikael Runhem
62%
|
|
![]() |
Nikesh Arora
62%
|
|
![]() |
Peter Sterky
62%
|
|
![]() |
Syntrans
62%
|
|
![]() |
Tequity
62%
|
|
![]() |
Felix Hagnö
62%
|
|